DNA Link Inc. (127120) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for DNA Link Inc. (127120:KRX), powered by AI.

Current Price
₩35,700
P/E Ratio
-75.4
Market Cap
1.2T
Sector
Healthcare
What is the DNA Link Inc. stock price forecast?

DNA Link Inc. is currently trading at ₩35,700. View real-time AI analysis on Alpha Lenz.

What is DNA Link Inc. insider trading activity?

View the latest insider trading data for DNA Link Inc. on Alpha Lenz.

What is DNA Link Inc.'s P/E ratio?

DNA Link Inc.'s P/E ratio is -75.4.

DNA Link Inc.

KRX · 127120
₩35,700+2,750(+8.35%)Market closedKRX regular session 09:00–15:30 KST
Ask about DNA Link Inc.'s future dividend policy...
Alpha Chat Insight

DNA Link Inc. trades at a P/E of -75.4 (undervalued) with modest ROE of -35.1%.

Ask for details

Company Overview

DNA Link Inc. is a biotechnology company focused on genomic analysis and personalized medicine. The primary function of the company is to provide advanced genomic services that integrate DNA research with practical healthcare solutions. Known for its cutting-edge genomic sequencing and analysis, DNA Link Inc. plays a crucial role in various sectors including clinical diagnostics, drug discovery, and molecular epidemiology. This company contributes significantly to advancements in healthcare by leveraging biotechnology to tailor individualized treatment plans and enhance patient care. Its work in genomic research impacts pharmaceuticals, genetic research labs, and healthcare institutions, supporting innovations in personalized therapy and disease prevention. As an integral part of the biotechnology market, DNA Link Inc. is instrumental in progressing the applications of genomic information in medical science.

CEO이준영
SectorHealthcare
IndustryBiotechnology
Employees83

Company Statistics

FY 2025

Profile

₩1,240,267,337,400Market Cap
₩19,316,467,820Revenue
34.74MShares Out
83Employees

Margins

18.88%Gross
-45.27%EBITDA
-63.13%Operating
-85.14%Pre-Tax
-85.14%Net

Valuation

-75.42P/E
18.08P/B
64.21EV/Sales
-142.18EV/EBITDA
-23.20P/FCF

Growth (CAGR)

4.39%Rev 3Yr
4.79%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-18.54%ROA
-35.13%ROE
-16.13%ROIC

Financial Health

₩40,430,705,640Cash & Cash Equivalents
₩14,012,853,480Net Debt
79.37%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

DNA Link Inc. (ticker: 127120) is a company listed on KRX in the Healthcare sector (Biotechnology). It has approximately 83 employees. Market cap is $1.2T.

The current price is ₩35,700 with a P/E ratio of -75.42x and P/B of 18.08x.

ROE is -35.13% and operating margin is -63.13%. Annual revenue is $19.3B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
DNA Link Inc. (127120) Stock Forecast 2026 ₩35,700 — Price, Financials & Analyst Targets | Alpha Lenz